George A. Mansoor – författare

This indispensable guide critically evaluates for hypertension specialists both established and new techniques for diagnosing and treating secondary hypertension in adults and children. Drawing on a variety of medical disciplines - including nephrology, endocrinology, internal medicine, and pediatrics - its world-renowned authors review the critical scenarios that should prompt a search for secondary forms of hypertension, and detail appropriate testing for these uncommon disorders. Additional coverage is given to exogenous or such less-appreciated causes of secondary hypertension as obstructive sleep apnea, primary aldosteronism, renovascular hypertension, and the effects of noncardiac drugs.

Secondary forms of hypertension are not uncommon in clinical prac­ tice, but they are often overlooked or forgotten by clinicians in many fields of medicine. Dr. George Mansoor'' s volume on Secondary Hyper­ tension is an important contribution to the field of clinical hypertension and vascular diseases, since it brings up to date the numerous diagnostic and therapeutic advances in the evaluation for secondary types of hyper­ tension. In the past, textbooks usually stated that an etiology could be determined in less than 5% of patients presenting with newly diagnosed hypertension. We now know this is far too low a proportion (e.g., pri­ mary hyperaldosteronism alone may account for hypertension in 5% of patients presenting with chronic elevations in blood pressure). Secondary Hypertension has been thoughtfully organized into chap­ ters evaluating screening and diagnosis, as well as medical and/or sur­ gical intervention of the well-known etiologies of secondary hypertension in adults and children. Additional coverage is given to such exogenous or lesser appreciated causes of secondary hypertension as obstructive sleep apnea and drugs. These sections make this book novel because in the past little attention has been paid to the effects of noncar­ diac drugs that interfere with antihypertensive therapy or to exogenous substances that might induce refractory hypertension.